MENU
+Compare
PRPO
Stock ticker: NASDAQ
AS OF
Dec 18, 04:36 PM (EDT)
Price
$5.77
Change
+$0.07 (+1.23%)
Capitalization
9.51M

PRPO Precipio Forecast, Technical & Fundamental Analysis

a provider of medical diagnostics services

PRPO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for PRPO with price predictions
Dec 17, 2024

PRPO's Stochastic Oscillator stoops into oversold zone

The Stochastic Oscillator for PRPO moved into oversold territory on December 17, 2024. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PRPO just turned positive on December 10, 2024. Looking at past instances where PRPO's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PRPO advanced for three days, in of 206 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 13, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on PRPO as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRPO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PRPO broke above its upper Bollinger Band on December 12, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PRPO entered a downward trend on December 02, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.751) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.634) is also within normal values, averaging (43.338).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PRPO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRPO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
PRPO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PRPO is expected to report earnings to fall 11.11% to -160 cents per share on November 13

Precipio PRPO Stock Earnings Reports
Q3'23
Est.
$-1.60
Q2'23
Beat
by $0.20
Q1'23
Missed
by $2.47
Q4'22
Missed
by $1.97
Q3'22
Missed
by $2.76
The last earnings report on August 01 showed earnings per share of -179 cents, beating the estimate of -200 cents. With 4.09K shares outstanding, the current market capitalization sits at 9.51M.
A.I. Advisor
published General Information

General Information

a provider of medical diagnostics services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4 Science Park
Phone
+1 203 787-7888
Employees
56
Web
https://www.precipiodx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCGVX33.34-0.10
-0.30%
Sands Capital Global Growth Inv
GEFPX15.94-0.10
-0.62%
Gotham Enhanced 500 Plus Institutional
EKGAX37.67-0.36
-0.95%
Allspring Special Global Small Cap A
HIASX18.60-0.20
-1.06%
Hartford Small Company HLS IA
JCNCX24.56-0.41
-1.64%
Janus Henderson Contrarian C

PRPO and Stocks

Correlation & Price change

A.I.dvisor tells us that PRPO and APDN have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRPO and APDN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRPO
1D Price
Change %
PRPO100%
-2.80%
APDN - PRPO
27%
Poorly correlated
+24.46%
VTAK - PRPO
27%
Poorly correlated
-3.45%
TNON - PRPO
27%
Poorly correlated
-1.55%
CSTL - PRPO
26%
Poorly correlated
-2.29%
TIVC - PRPO
25%
Poorly correlated
+3.77%
More